Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
46,305
-
Share change
-
+46,282
-
Total reported value
-
$400,196
-
Price per share
-
$8.64
-
Number of holders
-
16
-
Value change
-
+$399,997
-
Number of buys
-
15
Institutional Holders of MiNK Therapeutics, Inc. - COM NEW (INKT) as of Q1 2025
As of 31 Mar 2025,
MiNK Therapeutics, Inc. - COM NEW (INKT) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,305 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, OSAIC HOLDINGS, INC., Tower Research Capital LLC (TRC), Covestor Ltd, and JPMORGAN CHASE & CO.
This page lists
16
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.